# Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

> **NCT07085572** · PHASE2 · RECRUITING · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 31 (estimated)

## Conditions studied

- Adrenal Cortical Carcinoma

## Interventions

- **DRUG:** Cemiplimab

## Key facts

- **NCT ID:** NCT07085572
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-18
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07085572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07085572, "Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07085572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*